about
Genomic alterations in pancreatic cancer and their relevance to therapyPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsCDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.Personalized medicine in sporadic pancreatic cancer without homologous recombination-deficiency: are we any closer?Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signalingA functional proteomic method for biomarker discovery.Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.An NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology.Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesionsCirculating tumor cells: exploring intratumor heterogeneity of colorectal cancerMiniaturized Real-Time PCR on a Q3 System for Rapid KRAS GenotypingPancreatic cancer genomics: insights and opportunities for clinical translationRapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps.In Silico Screening of Mutated K-Ras Inhibitors from Malaysian Typhonium flagelliforme for Non-Small Cell Lung Cancer.MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells.Biology of colorectal cancer.Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study.Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer.Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer.Advances in gas chromatographic methods for the identification of biomarkers in cancer.KRAS Testing: A Tool for the Implementation of Personalized Medicine.A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors.Meganucleases Revolutionize the Production of Genetically Engineered Pigs for the Study of Human Diseases.Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing.hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism.Mouse models for gastric cancer: Matching models to biological questions.Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3pMorphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats.MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications.Cancer biomarker discovery: current status and future perspectives.KRAS mutation testing in clinical practice.A ceRNA analysis on LMNA gene focusing on the Hutchinson-Gilford progeria syndrome.miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.Diagnosis and Molecular Classification of Lung Cancer.KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
P2860
Q26781443-68E20A64-3C7E-478C-81AB-E57F80D18CBDQ26862544-94A89328-B520-4B27-B6D7-62BB2E4FC3A1Q27853338-CB58ECAD-CE39-4378-B2CC-464EF6214BBEQ28066268-B9D9F9EF-8E78-4A4B-AEC2-8528157319BAQ28078716-428E5A98-FF67-41AB-9703-8551B47E1544Q30431185-2320E930-72EA-417E-ACD1-9F3AA3B41A00Q30763468-C5A3EE24-80E7-44BF-8D00-1A98688B2180Q31077769-98496812-27EE-475C-B132-1BB84B8D872EQ31157579-DA2EA239-CDFB-4226-B786-D359744906DAQ33631430-567BA42C-239F-41FA-A6BD-09EFD45C1EA3Q33649652-F77E42DC-9F01-4578-98A7-CEF3D489D06EQ33781071-1D22DA4D-C481-4B0D-99D1-83F107DBA155Q33847505-6D6C7DFC-6DB5-4A7C-B575-55FF9F25E6FBQ34104005-3A62A672-B6E8-4DD7-A04E-69054246280BQ34163458-15E99082-4079-432E-8977-DCFBA5A44B75Q34305736-C21CC02F-E72D-48E0-AAEA-CFB2A4B82D49Q34332924-FAD7F5A6-2F5D-4127-8393-723C6F13EA14Q34669618-1E80EB81-04F2-4131-A31F-623FBEC48D8CQ35045928-6E6AE189-A103-4005-A0A7-872F429A4CEFQ35213124-6A03E701-04E0-4B81-93A9-24F2B7FFEEFEQ35723937-5EC59817-8984-4E57-A0E4-48CD295FCC99Q36316592-93C01874-63C7-4C35-BA2E-79F6BCCB7D82Q36481945-CBACBA8A-E1AB-457A-8AE0-4481C7755FF7Q36523724-BB225C6C-F0FC-4473-942B-74B8C8183CF0Q36588574-41AAA2DC-4A60-4901-90B4-B8CC6043112CQ36723065-0D8695C1-3755-4D23-AE79-547D87D72D3FQ37241845-6340D1FF-CD90-4F99-80A1-43E9FE05118FQ37407226-F9940152-C45E-4418-9053-B3E7D81435C4Q37644785-E23E1FF7-687A-4BAD-9BA0-555E85E352ECQ37664258-50E8DD9D-ADBD-4D11-8774-C266A754333CQ37691771-F870FB27-1794-43E8-961E-C9E362BEC9E7Q37831162-1C1FDE6B-AF85-40BD-8A56-90761AEA6A0FQ37857375-B4B1C901-C8C0-4276-B6B3-DF10FBB5C1B7Q38187679-87B0A88D-3965-44E8-9531-372F52F593D7Q38285393-ECCFF83E-3D29-4DDD-B750-4FA61B57A164Q38492694-F77BE2B8-1BAC-4D64-A7D2-0EEFEE51A565Q38795917-2B925952-FB74-49DC-9054-611EB72EEE47Q38930336-8EF19C95-E265-4E7F-8F23-E371989E9F9CQ39270840-E5CECBFA-CF2C-475A-93DE-35728597F061Q39482095-C942524B-8677-45DE-A533-CEA4DA41B9A6
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical relevance of KRAS in human cancers.
@ast
Clinical relevance of KRAS in human cancers.
@en
type
label
Clinical relevance of KRAS in human cancers.
@ast
Clinical relevance of KRAS in human cancers.
@en
prefLabel
Clinical relevance of KRAS in human cancers.
@ast
Clinical relevance of KRAS in human cancers.
@en
P2093
P2860
P921
P356
P1476
Clinical relevance of KRAS in human cancers.
@en
P2093
Danuta Radzioch
Jirí Drábek
Marián Hajdúch
Sylwia Jancík
P2860
P304
P356
10.1155/2010/150960
P577
2010-06-07T00:00:00Z